TD Cowen raises Prudential Financial's price target to $113, maintaining a 'Hold' rating, as the insurer grapples with a misconduct scandal at its Japan life insurance unit affecting nearly 500 customers.
Amidst a mixed economic backdrop, we spotlight three U.S. tech companies—Rumble, Daktronics, and Sandisk—whose strategic initiatives and robust growth projections set them apart for investors looking beyond near-term turbulence.
Alphabet's self-driving unit Waymo is in advanced talks to secure a massive $16 billion funding round, potentially valuing the company at around $110 billion, as competition in the robotaxi market intensifies.
Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.
While Tesla's stock remains resilient, the promise of a self-driving future presents both staggering potential and significant hurdles for investors to consider.
Vice President Sara Duterte faces renewed impeachment efforts in the Philippine Congress, centered on allegations of misusing millions in confidential funds. The move reignites political tensions in a nation grappling with the legacies of powerful political dynasties.
While small-cap stocks offer significant growth potential, their volatility demands careful selection. We analyze one standout and two struggling companies in the Russell 2000 index this week.
Security forces are engaged in extensive operations across Balochistan following a devastating wave of coordinated assaults by separatist militants on civilian and government targets over the weekend, which killed nearly 50 people and marked a significant escalation in the long-running conflict.
Amid a contentious federal immigration operation, Minneapolis residents report heightened tensions and an increased security presence, contradicting official promises of de-escalation. The arrests of journalists and unresolved fatal shootings have intensified scrutiny and community-led resistance.
A deep dive into the shareholder structure of Marten Transport, Ltd. (NASDAQ:MRTN) reveals a landscape dominated by institutional investors, whose collective actions can significantly sway the stock's trajectory. With the CEO also holding a substantial stake, we examine the balance of power and what it means for the company's future.
Pharmaceutical giant Eli Lilly announces a massive $3.5 billion investment in a new Pennsylvania manufacturing facility dedicated to next-generation weight-loss drugs, signaling a long-term strategic commitment to the obesity market amid intense competition.
A Gwinnett County police officer was fatally shot and his partner seriously wounded Sunday while questioning a suspect in a hotel room near Stone Mountain. The gunman, who had an active warrant, invited the officers inside before opening fire.
Kuwait mandates sweeping regulations on food delivery platforms, capping commissions and banning exclusivity deals after uncovering anti-competitive practices that hurt restaurants and consumers.
Lyft shares have dramatically outperformed the S&P 500, climbing nearly 20% in six months. While rider growth and improving cash flow paint an optimistic picture, underlying margin pressures reveal the intense competition in the ride-hailing sector.
Amidst a cautious market climate, companies with substantial insider ownership often signal strong internal conviction. We examine three such firms—spanning South Korean tourism, Chinese sensors, and Taiwanese biopharma—where executives and directors have significant skin in the game.
While often operating behind the scenes, industrial companies are the engine of the U.S. economy. Bolstered by a favorable interest rate environment, the sector has surged 18.8% in the last six months, significantly outpacing the S&P 500. We analyze two firms with durable competitive edges and one that may be losing momentum.
Despite reporting revenue and earnings that topped Wall Street forecasts, Triumph Financial's stock fell post-earnings. While management pointed to strength in its payments network and cost controls, analysts on the call focused on persistent challenges in the freight sector and the sustainability of margins.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
Alphabet's self-driving subsidiary Waymo is reportedly seeking a new funding round that would value the company at approximately $110 billion, drawing fresh attention to the tech giant's ambitious bets beyond its core advertising business and the evolving landscape of autonomous vehicle investment.
A wave of commercial flight disruptions is pushing a new class of travelers toward private aviation, not for opulence but for reliability. We examine the shifting calculus of air travel and what a seat actually costs.
